- Home
- PPCB vs CCEL Comparison
PPCB vs CCEL Comparison
Compare PPCB & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPCB
- CCEL
- Stock Information
- Founded
- PPCB 2007
- CCEL 1989
- Country
- PPCB Australia
- CCEL United States
- Employees
- PPCB N/A
- CCEL N/A
- Industry
- PPCB
- CCEL Managed Health Care
- Sector
- PPCB
- CCEL Health Care
- Exchange
- PPCB Nasdaq
- CCEL Nasdaq
- Market Cap
- PPCB 39.1M
- CCEL 34.8M
- IPO Year
- PPCB N/A
- CCEL 1997
- Fundamental
- Price
- PPCB $2.25
- CCEL $4.38
- Analyst Decision
- PPCB
- CCEL Strong Buy
- Analyst Count
- PPCB 0
- CCEL 1
- Target Price
- PPCB N/A
- CCEL $8.50
- AVG Volume (30 Days)
- PPCB 5.4M
- CCEL 25.7K
- Earning Date
- PPCB 09-30-2025
- CCEL 10-14-2025
- Dividend Yield
- PPCB N/A
- CCEL 13.76%
- EPS Growth
- PPCB N/A
- CCEL N/A
- EPS
- PPCB N/A
- CCEL N/A
- Revenue
- PPCB N/A
- CCEL $31,988,783.00
- Revenue This Year
- PPCB N/A
- CCEL $1.75
- Revenue Next Year
- PPCB N/A
- CCEL N/A
- P/E Ratio
- PPCB N/A
- CCEL N/A
- Revenue Growth
- PPCB N/A
- CCEL 1.10
- 52 Week Low
- PPCB $0.00
- CCEL $4.09
- 52 Week High
- PPCB $145.46
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- PPCB N/A
- CCEL 44.09
- Support Level
- PPCB N/A
- CCEL $4.20
- Resistance Level
- PPCB N/A
- CCEL $4.70
- Average True Range (ATR)
- PPCB 0.00
- CCEL 0.21
- MACD
- PPCB 0.00
- CCEL 0.00
- Stochastic Oscillator
- PPCB 0.00
- CCEL 29.03
About PPCB Propanc Biopharma Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.